Fewer hepatologists and gastroenterologists prescribed anti-obesity medications and diabetes medications such as pioglitazone (41%), metformin (39%), GLP-1 receptor agonists (22%), and SGLT-2 inhibitors (12%) (Fig. 5). Here, SLC5A2 is linked to obesity due to melanocortin 4 receptor deficiency.